RAP 0.00% 20.5¢ resapp health limited

Ann: ResAppDx-EU in Use at COVID-19 Respiratory Clinic, page-88

  1. 1,916 Posts.
    lightbulb Created with Sketch. 1585
    ResApp needs to demonstrate to the FDA that the probable benefits of the device outweigh its probable risks
    Today's announcement and feedback from these 65 GP's will help with that decision.


    Regards
    Bloky
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.